Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
Rhea-AI Summary
Enovis (NYSE: ENOV) announced it will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at Encore Boston Harbor. CEO Damien McDonald and CFO Ben Berry will join a fireside chat at 1:30 p.m. Eastern Time. A live audio webcast and replay will be accessible through the company’s website under the Investors > Events and Presentations section.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 06 | 2Q26 earnings | Positive | -12.8% | Reported Q2 sales growth, margin improvement, and reaffirmed 2026 guidance |
| Jul 17 | Earnings call scheduling | Neutral | -3.6% | Announced Q2 results call logistics ahead of scheduled August 6 reporting |
| Jul 13 | Veterinary product launch | Positive | +1.9% | U.S. launch of CT-RevitL veterinary photobiomodulation laser therapy system |
| Jun 08 | Scoliosis brace launch | Positive | -0.4% | Launched hybrid scoliosis brace with corrective elements and adjustable vest |
| May 07 | 1Q26 earnings | Positive | +9.7% | Reported Q1 sales growth, adjusted EBITDA, and reaffirmed full-year guidance |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Enovis showed mixed reactions: positive operating or product news aligned with gains in two cases but diverged in three, including a -12.82% move after Q2 results.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Dallas, TX, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in the 2026 Wells Fargo HealthCare conference on Tuesday, September 8, 2026 at the Encore Boston Harbor.
Damien McDonald, Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat session at 1:30 p.m. Eastern Time. A link to the live audio webcast, as well as a replay of the event, will be available on the Company’s website under the Investors tab at Events and Presentations.
About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com and follow us on Facebook, Instagram, LinkedIn and X.
Investor Contact
Kyle Rose, Vice President, Investor Relations
investorrelations@enovis.com
Media Contact
Rachel Colloff, Sr. Director, Corporate Communications
Rachel.Colloff@enovis.com
